Patricia Inacio is a science writer for Alzheimer's News Today with a PhD in cell biology. She covers the latest news and information on a variety of Alzheimer's topics.| Alzheimer's News Today
Alpha Cognition’s ALPHA-1062 for Alzheimer’s showed efficacy in a trial as a bioequivalent substitute for the approved therapy Razadyne.| Alzheimer's News Today
Zunveyl, a new oral mild-to-moderate Alzheimer's therapy, showed bioequivalence to galanotamine but fewer GI issues like nausea in studies.| Alzheimer's News Today